| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.007 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.008 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.008 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.009 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |